Who owns Scpharmaceuticals Inc?
- Ticker: SCPH
- CUSIP Number: 810648105
Tip: Access positions for across all investors
Analyze quarterly positions in Scpharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Scpharmaceuticals stock
Who bought or sold Scpharmaceuticals Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
OrbiMed Advisors | 6.1M | $28M | 9% | Sep 2024 |
|
Rubric Capital Management | 4.8M | $22M | 35% | Sep 2024 |
|
AIGH Capital Management | 4.1M | $19M | 18% | Sep 2024 |
|
Luther King Capital Management Corporation | 2.2M | $10M | 1% | Sep 2024 |
|
BlackRock | 1.9M | $8.5M | 100% | Sep 2024 |
|
BlackRock | 1.8M | $7.7M | -2% | Jun 2024 |
|
Vanguard Group | 1.4M | $6.0M | 1% | Jun 2024 |
|
5AM Venture Management | 1.2M | $5.5M | 0% | Sep 2024 |
|
Thrivent Financial for Lutherans | 1.0M | $4.8M | -2% | Sep 2024 |
|
J. Goldman & Co | 870k | $3.8M | -22% | Jun 2024 |
|
Stonepine Capital Management | 779k | $3.6M | 85% | Sep 2024 |
|
AWM Investment Company | 765k | $3.5M | 100% | Sep 2024 |
|
Nantahala Capital Management | 750k | $3.4M | 100% | Sep 2024 |
|
Tejara Capital | 650k | $3.0M | -7% | Sep 2024 |
|
State Street Corporation | 648k | $2.8M | 13% | Jun 2024 |
|
Geode Capital Management | 643k | $2.9M | 11% | Sep 2024 |
|
Rice Hall James & Associates | 622k | $2.8M | 25% | Sep 2024 |
|
Citadel Advisors | 559k | $2.5M | -27% | Sep 2024 |
|
Woodline Partners | 502k | $2.3M | 100% | Sep 2024 |
|
Monashee Investment Management | 320k | $1.5M | 100% | Sep 2024 |
|
Northern Trust | 255k | $1.2M | -4% | Sep 2024 |
|
Morgan Stanley | 221k | $963k | 22% | Jun 2024 |
|
Kennedy Capital Management | 219k | $952k | 0% | Jun 2024 |
|
Bridgeway Capital Management | 189k | $822k | 0% | Jun 2024 |
|
Apis Capital Advisors | 160k | $730k | 100% | Sep 2024 |
|
Susquehanna International | 108k | $494k | 202% | Sep 2024 |
|
Nuveen Asset Management | 91k | $394k | 0% | Jun 2024 |
|
Raymond James & Associates | 81k | $368k | -6% | Sep 2024 |
|
Charles Schwab Investment Management | 76k | $346k | -4% | Sep 2024 |
|
Bank of New York Mellon | 69k | $315k | -20% | Sep 2024 |
|
Group One Trading | 64k | $291k | 100% | Sep 2024 |
|
Balanced Rock Investment Advisors | 63k | $275k | 10% | Jun 2024 |
|
Renaissance Technologies | 59k | $268k | -73% | Sep 2024 |
|
Barclays | 41k | $186k | 317% | Sep 2024 |
|
Bank of America Corporation | 40k | $184k | 7% | Sep 2024 |
|
Commonwealth Equity Services | 39k | $177k | 5% | Sep 2024 |
|
TNB Financial | 38k | $171k | 0% | Sep 2024 |
|
Rhumbline Advisers | 35k | $162k | -7% | Sep 2024 |
|
Goldman Sachs Group | 35k | $150k | 22% | Jun 2024 |
|
Scoggin | 34k | $155k | 100% | Sep 2024 |
|
Dimensional Fund Advisors | 33k | $151k | -75% | Sep 2024 |
|
Citigroup | 28k | $130k | 360% | Sep 2024 |
|
Marshall Wace | 24k | $108k | 100% | Sep 2024 |
|
Jane Street | 24k | $107k | -46% | Sep 2024 |
|
Invesco | 22k | $98k | -5% | Sep 2024 |
|
Squarepoint Ops | 20k | $85k | -69% | Jun 2024 |
|
Captrust Financial Advisors | 19k | $85k | 32% | Sep 2024 |
|
Mitsubishi UFJ Asset Management | 18k | $81k | -14% | Sep 2024 |
|
MetLife Investment Advisors | 17k | $77k | 135% | Sep 2024 |
|
Perkins Capital Management | 16k | $74k | -12% | Sep 2024 |
|
Mirae Asset Global Etfs Holdings | 16k | $74k | 10% | Sep 2024 |
|
Sherbrooke Park Advisers | 15k | $70k | -47% | Sep 2024 |
|
Alliancebernstein | 15k | $66k | 47% | Jun 2024 |
|
PDT Partners | 15k | $69k | -13% | Sep 2024 |
|
Simplex Trading | 15k | $66k | 100% | Sep 2024 |
|
Brian McDonald | 14k | $63k | 100% | Sep 2024 |
|
Deutsche Bank Aktiengesellschaft | 13k | $61k | 0% | Sep 2024 |
|
Jpmorgan Chase & Co | 12k | $56k | -3% | Sep 2024 |
|
IPG Investment Advisors | 12k | $52k | 0% | Jun 2024 |
|
New York State Common Retirement Fund | 12k | $53k | 0% | Sep 2024 |
|
Ing Investment Management | 11k | $52k | -1% | Sep 2024 |
|
Pinnacle Wealth Planning Services | 11k | $51k | 0% | Sep 2024 |
|
Sandy Cove Advisors | 11k | $48k | 0% | Sep 2024 |
|
Acadian Asset Management | 9.1k | $41k | 100% | Sep 2024 |
|
Wells Fargo & Company | 8.7k | $40k | -4% | Sep 2024 |
|
Tower Research Capital | 7.1k | $31k | -33% | Jun 2024 |
|
Bnp Paribas Arbitrage, Snc | 5.8k | $26k | 117% | Sep 2024 |
|
Advisor Group Holdings | 5.6k | $26k | 0% | Sep 2024 |
|
Royal Bank of Canada | 3.0k | $13k | 10% | Sep 2024 |
|
Summit Investment Advisors | 2.4k | $11k | 0% | Sep 2024 |
|
California State Teachers Retirement System | 2.1k | $9.4k | 0% | Sep 2024 |
|
BFSG | 2.0k | $9.1k | 100% | Sep 2024 |
|
Amalgamated Bank | 973.00 | $4.0k | 0% | Sep 2024 |
|
CWM | 692.00 | $3.0k | 158% | Sep 2024 |
|
International Assets Investment Management | 456.00 | $100k | 356% | Sep 2024 |
|
Atlantic Edge Private Wealth Management | 425.00 | $1.9k | 0% | Sep 2024 |
|
GAMMA Investing | 265.00 | $1.2k | 162% | Sep 2024 |
|
Covestor | 151.00 | $999.997500 | 100% | Sep 2024 |
|
NISA Investment Advisors | 148.00 | $674.998400 | 3% | Sep 2024 |
|
Pnc Financial Services | 92.00 | $419.998400 | 0% | Sep 2024 |
|
Capital Performance Advisors | 85.00 | $387.999500 | 100% | Sep 2024 |
|
Russell Investments | 44.00 | $190.999600 | 100% | Jun 2024 |
|
Sterling Capital Management | 29.00 | $131.999300 | 100% | Sep 2024 |
|
Who sold out of Scpharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Millennium Management | Jun 2024 | 130k | $566k |
Assenagon Asset Management | Jun 2024 | 73k | $316k |
Virtu Financial | Mar 2024 | 18k | $90k |
Trexquant Investment | Jun 2024 | 14k | $61k |
Manufacturers Life Insurance Company | Mar 2024 | 12k | $62k |
Worth Venture Partners | Mar 2024 | 2.3k | $12k |
Massmutual Trust | Jun 2024 | 389.00 | $1.7k |